StockData
SBC Medical Group Holdings Inc logo

SBC Medical Group Holdings Inc (SBC) company profile

SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3014% below fair value
$7.35+2.01 (+37.64%)

Close on Nov 13, 2026Market cap $755.93MP/E 15.6Yield –

About SBC Medical

Services-Offices & Clinics of Doctors of Medicine, SIC 8011

SBC Medical Group Holdings Incorporated operates as a healthcare services and clinic management holding company. Through its operating subsidiaries, the company provides support services to healthcare providers, which include medical corporations, franchisee clinics, and independent physicians. Its core business activities encompass management services, clinic franchising, procurement services, and equipment or facility rental services. The company primarily serves healthcare partners, medical corporations, and affiliated clinics that offer medical treatments, aesthetic healthcare, cosmetic surgery, and osteopathic care.

The company maintains business operations and clinic affiliations internationally, with activities and subsidiaries located across Japan, Singapore, Vietnam, and the United States. Its network includes medical corporations and independently operated clinics across these jurisdictions. SBC Medical Group Holdings Incorporated maintains its principal executive offices and corporate headquarters in Irvine, California.

Summary of the business section of SBC Medical's latest annual report, written by StockData.

Company profile

Company

Legal name
SBC Medical Group Holdings Inc
Founded
2022
Headquarters
Irvine, CA
Address
200 Spectrum Center Dr., Suite 300 92618
Phone
(949) 593-0250
Employees
863, Dec 31, 2025
Industry
Services-Offices & Clinics of Doctors of Medicine
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
MaloneBailey, LLP, Tokyo, Japan

Stock & identifiers

Ticker
SBC
Other tickers
SBCWW
Former tickers
PTWO until Sep 20, 2024
Exchange
Nasdaq
IPO date
Aug 8, 2022
Shares outstanding
103M, Jul 31, 2026
Public float
$48.20M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
1930313
CUSIP
73245B107
ISIN
US73245B1070
FIGI
BBG019TC4SS5
Share class FIGI
BBG019TC4TM9
EIN
88-1263511

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yoshiyuki AikawaChairman and CEO, Director83,839,460
Miki YamazakiChief Strategy Officer–

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusTotalvs. prior year
Yoshiyuki Aikawa
Chief Executive Officer (principal executive officer)
$12.00M–$12.00M-17%
Yuya Yoshida
Chief Financial Officer and Chief Operating Officer
$316.73K$99.34K$416.07K+37%
Miki (Shimizu) Yamazaki
Chief Strategy Officer
$275.78K$83.39K$359.17K–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Aug 8, 2022
Offer price
$10.00
Securities offered
10,000,000
Gross proceeds
$100.00M
Exchange
Nasdaq
First trading day
Sep 26, 2022
First-day close
$9.96-0.4%
Lock-up ends (est.)
Mar 25, 2023

“Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one redeemable warrant.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 863 regular employees globally (excluding employees of the managed clinics/medical corporations we support), a majority of which are located in Japan, Singapore, Vietnam, and the United States.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?